
Results
35
Stocks where the price continues to rise after more than a year of consistent gains.
35 companies
Moderna
Market Cap: US$57.9b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$145.13
7D
125.1%
1Y
472.5%
BioNTech
Market Cap: US$29.3b
Engages in the development and commercialization of immunotherapies in Germany.
BNTX
US$112.82
7D
23.2%
1Y
7.4%
Genscript Biotech
Market Cap: HK$71.3b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$32.62
7D
25.1%
1Y
69.2%
Hanmi Pharm
Market Cap: ₩6.9t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩540,000.00
7D
35.5%
1Y
86.2%
Amylyx Pharmaceuticals
Market Cap: US$4.3b
A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.
AMLX
US$38.15
7D
78.0%
1Y
348.8%
Maravai LifeSciences Holdings
Market Cap: US$2.2b
A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.
MRVI
US$8.43
7D
48.4%
1Y
251.3%
Xencor
Market Cap: US$2.1b
A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases.
XNCR
US$27.80
7D
20.2%
1Y
247.1%
Personalis
Market Cap: US$2.0b
Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
PSNL
US$18.38
7D
32.3%
1Y
291.1%
Jenkem Technology
Market Cap: CN¥7.5b
Engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol (PEG), and its derivatives in China and internationally.
688356
CN¥124.00
7D
55.0%
1Y
25.9%
Immix Biopharma
Market Cap: US$977.2m
A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.
IMMX
US$13.61
7D
20.0%
1Y
548.1%
Hunan Hansen Pharmaceutical
Market Cap: CN¥5.6b
Engages in the production and sale of traditional Chinese preparations in China and internationally.
002412
CN¥11.21
7D
49.3%
1Y
60.8%
Nuvectis Pharma
Market Cap: US$767.6m
A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.
NVCT
US$23.87
7D
25.1%
1Y
267.8%
Shanghai Shenqi Pharmaceutical Investment Management
Market Cap: CN¥4.9b
Operates as a pharmaceutical manufacturing holding investment company in China.
600613
CN¥9.90
7D
40.4%
1Y
40.8%
Xinjiang Tianshan Animal Husbandry Bio-engineering
Market Cap: CN¥3.7b
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.
300313
CN¥15.36
7D
43.2%
1Y
74.9%
ACRO Biomedical
Market Cap: NT$15.0b
Develops medical-grade regenerative biomaterials in Taiwan, Vietnam, and internationally.
6748
NT$210.50
7D
21.0%
1Y
158.3%
ProQR Therapeutics
Market Cap: US$330.2m
A clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines.
PRQR
US$2.43
7D
25.9%
1Y
8.0%
Solara Active Pharma Sciences
Market Cap: ₹30.3b
Manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally.
SOLARA
₹629.10
7D
23.6%
1Y
0.4%
AVITA Medical
Market Cap: US$311.1m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$9.91
7D
25.4%
1Y
113.1%
Circio Holding
Market Cap: NOK 2.2b
A biotechnology company, develops novel circular RNA expression technology for gene and cell therapy.
CRNA
NOK 10.92
7D
25.5%
1Y
1,717.0%
Journey Medical
Market Cap: US$218.7m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$7.91
7D
22.4%
1Y
6.9%
Nykode Therapeutics
Market Cap: NOK 1.5b
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.
NYKD
NOK 4.56
7D
36.1%
1Y
153.3%
Cypherpunk Technologies
Market Cap: US$153.0m
A privacy technology company, implements a digital asset strategy anchored by Zcash in the United States.
CYPH
US$1.68
7D
138.2%
1Y
441.9%
More Life
Market Cap: CA$34.3m
A biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada.
MLCO
CA$0.08
7D
33.3%
1Y
433.3%
Marker Therapeutics
Market Cap: US$23.2m
A clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States.
MRKR
US$1.50
7D
29.3%
1Y
19.0%
Pharmala Biotech Holdings
Market Cap: CA$28.9m
A biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.
MDMA
CA$0.26
7D
36.8%
1Y
108.0%
BioVie
Market Cap: US$14.7m
A clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States.
BIVI
US$2.14
7D
82.9%
1Y
29.7%
Malaysian Genomics Resource Centre Berhad
Market Cap: RM 57.4m
Provides genetics, genomics, immunotherapy, and biopharmaceutical services in Malaysia.
MGRC
RM 0.38
7D
22.6%
1Y
94.9%
Makers Laboratories
Market Cap: ₹1.3b
An integrated pharmaceutical company, manufactures and markets formulations in India.
506919
₹221.80
7D
41.6%
1Y
51.8%
TME Pharma
Market Cap: €8.4m
A clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany.
ALTME
€0.16
7D
105.3%
1Y
44.4%
International Stem Cell
Market Cap: US$4.0m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.50
7D
25.1%
1Y
241.8%
Emmaus Life Sciences
Market Cap: US$2.3m
A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.
EMMA
US$0.041
7D
256.5%
1Y
247.5%
Orgenesis
Market Cap: US$980.0k
A biotech company, focuses on cell and gene therapies in the United States.
ORGS
US$0.59
7D
68.6%
1Y
490.0%
PAO Group
Market Cap: US$573.1k
Focuses on alternative patient care treatments.
PAOG
US$0.0003
7D
200.0%
1Y
29,900.0%
Neutra
Market Cap: US$304.3k
Researches, develops, and provides hemp-derived products in the nutraceutical space in the United States.
NTRR
US$0.0002
7D
100.0%
1Y
0%
Cannonau
Market Cap: US$48.4k
Engages in the provision of cannabidiol based products.
CNNC
US$0.0003
7D
50.0%
1Y
200.0%